News Investors Nasdaq: LGND Home About Portfolio Summary Technologies Licensing Opportunities ALL SEC FILINGS All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Filter Filings: View All 10-K 10-K/A 10-Q 10-Q/A 144 15-12G 3 3/A 4 4/A 424B1 424B3 424B5 425 5 8-A12B 8-A12G 8-A12G/A 8-K 8-K/A ARS CORRESP CT ORDER D DEF 14A DEFA14A DEFM14A DEFN14A DFAN14A EFFECT NT 10-K NT 10-Q POS AM PRE 14A PREM14A PREN14A PRER14A S-1 S-1/A S-3 S-3/A S-3ASR S-4 S-4/A S-8 S-8 POS SC 13D SC 13D/A SC 13E3 SC 13E3/A SC 13E4 SC 13E4/A SC 13G SC 13G/A SC TO-C SC TO-T SC TO-T/A UPLOAD Date Form Description Docs XBRL Pages 11/17/21 4 Statement of changes in beneficial ownership of securities 2 11/12/21 4 Statement of changes in beneficial ownership of securities 2 11/12/21 4 Statement of changes in beneficial ownership of securities 2 11/09/21 10-Q Quarterly report pursuant to Section 13 or 15(d) Related Documents 44 11/09/21 8-K Current report filing Related Documents 16 10/12/21 SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 5 08/16/21 8-K Current report filing 5 08/05/21 4 Statement of changes in beneficial ownership of securities 2 08/03/21 10-Q Quarterly report pursuant to Section 13 or 15(d) Related Documents 42 07/29/21 8-K Current report filing Related Documents 16 1 2 3 4 5 6 7 8 9 10 ...184 Next >> © 2021 Ligand Pharmaceuticals Incorporated All Rights Reserved. Privacy Policy Disclaimer Sitemap